Company: EVLVW
Filing Date: 2025-04-28
Form Type: 10-Q
Source: 0001628280-25-020353
Chunk: 174

Company: Evolv Technologies Holdings, Inc.
Filing Date: 2025-04-28
Form: 10-Q
Item: Part I, Item 1
Chunk 174
---
515 — — 515 Issuance of common stock upon vesting of restricted stock units155,624 — — — — — Stock-based compensation cost— — 7,781 — — 7,781 Cumulative translation adjustment— — — (86)— (86)Net loss— — — — (30,443)(30,443)Balances at September 30, 2024158,288,746 $16 $468,041 $(128)$(338,944)$128,985 

F-4

Common StockAdditionalPaid-inCapitalAccumulated Other Comprehensive Income (Loss)AccumulatedDeficitTotalStockholders’EquitySharesAmountBalances at December 31, 2022 (restated)145,204,974 $15 $419,212 $(10)$(192,599)$226,618 Issuance of common stock upon net exercise of stock options100,587 — 33 — — 33 Issuance of common stock upon vesting of restricted stock units1,841,257 — — — — — Issuance of common stock upon exercise of warrants830,216 — 348 — — 348 Stock-based compensation cost (restated)— — 5,092 — — 5,092 Cumulative translation adjustment— — — (16)— (16)Net loss (restated)— — — — (28,677)(28,677)Balances at March 31, 2023 (restated)147,977,034 $15 $424,685 $(26)$(221,276)$203,398 Issuance of common stock upon net exercise of stock options775,193 — 310 — — 310 Issuance of common stock upon vesting of restricted stock units1,038,415 — — — — — Issuance of common stock upon exercise of warrants100 — 1 — — 1 Stock-based compensation cost (restated)— — 6,788 — — 6,788 Cumulative translation adjustment— — — (17)— (17)Net loss (restated)— — — — (